EUVIMEDEUVIMED entdecken
Crossref

Reconsidering registration requirements for trials randomising health care providers

Karla Hemming iD, Monica Taljaard iD, Laura Kudrna, Joanne E McKenzie, Cory E Goldstein iD

Clinical Trials · 2026-06 · 23 (3) · 358-360

DOI: 10.1177/17407745261429958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Trials, online erschienen am 15.03.2026. Verfasst von Karla Hemming und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Health Research, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Health Personnel, Randomized Controlled Trials as Topic, Registries. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical trial registration plays a vital role in enhancing transparency, reducing reporting bias, and upholding the integrity of the evidence used in clinical and policy decision-making. The International Committee of Medical Journal Editors (ICMJE) has produced a set of recommendations covering trial registration for its member journals, but they are widely adopted by many journals. It recommends that trials are registered prospectively, and that trial registration is clearly reported in all related manuscripts. However, ICMJE’s recommendations are ambiguous when it comes to the registration of clinical trials involving healthcare providers (HCPs), indicating that if trials study the effect of an intervention only on HCPs (e.g. provider knowledge or attitudes), then registration is not necessary. In this commentary, we argue that all clinical trials involving HCPs should be registered for three reasons. First, these trials (like any other research) are at an increased risk of reporting bias should they not be registered prospectively. Second, when HCPs are research participants, they are deserving of the same ethical protections as other types of research participants (and this includes trial registration). Finally, not exempting these trials from registrations would bring ICMJE in line with other international guidelines for health research (which do not exempt them). We conclude by advocating for a revision of the ICMJE trial-registration recommendation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health PersonnelRandomized Controlled Trials as TopicRegistriesHumansEditorial Policies

Stichwörter der Autor:innen

Trial registrationethical requirementstrials of health care professionals

Autor:innen und Institutionen

  • Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Methodological and Implementation Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
  • Applied Health Sciences, University of Birmingham, Birmingham, UK.
  • Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

ORCID-Profile: Karla Hemming, Monica Taljaard, Cory E Goldstein

Zitieren

APA

Hemming, K., Taljaard, M., Kudrna, L., McKenzie, J. E., & Goldstein, C. E. (2026). Reconsidering registration requirements for trials randomising health care providers. Clinical Trials, 23(3), 358-360. https://doi.org/10.1177/17407745261429958

Vancouver

Hemming K, Taljaard M, Kudrna L, McKenzie JE, Goldstein CE. Reconsidering registration requirements for trials randomising health care providers. Clinical Trials. 2026;23(3):358-360. doi:10.1177/17407745261429958

BibTeX
@article{Hemming2026,
  author = {Hemming, Karla and Taljaard, Monica and Kudrna, Laura and McKenzie, Joanne E and Goldstein, Cory E},
  title = {Reconsidering registration requirements for trials randomising health care providers},
  journal = {Clinical Trials},
  year = {2026},
  volume = {23},
  number = {3},
  pages = {358--360},
  doi = {10.1177/17407745261429958}
}
Kostenlos starten →